Drag a card by its title · ⚙ to size, swap or remove

The company

ENDRA Life Sciences Inc.

NDRA · Nasdaq

Health CareMedical DevicesJust dropped out

NDRA stood above a rising 150-day average in 17 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 6.1% below that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−2 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation: Just dropped out
Weeks in an uptrend: out for 1
Industry in uptrend: 29% -2 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 10 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 17 of 52 weeks.

23 Apr – 22 Oct

Medical Devices: A minority of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months0

Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders10+2 on the quarter

New · exited3 · 1

Reported value$819K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Altium Capital Management LLCadded · filed 12 Aug 2026	59,272$316K	+7,372+14.2%
CITADEL ADVISORS LLCnew · filed 14 Aug 2026	29,924$159K	+29,924
CITIZENS FINANCIAL GROUP INCnew · filed 7 Aug 2026	28,400$151K	+28,400
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	14,910$79K	-6,168−29.3%
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026	10,121$54K	00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	7,339$39K	+4,523+160.6%
MORGAN STANLEYunchanged · filed 13 Aug 2026	3,546$19K	00.0%
UBS Group AGreduced · filed 13 Aug 2026	68$362	-84−55.3%
Tower Research Capital LLC (TRC)new · filed 11 Aug 2026	58$309	+58
NORTHWESTERN MUTUAL WEALTH MANAGEMENT COunchanged · filed 12 Aug 2026	19$101	00.0%

31 Dec 2024 – 30 Jun 2026

News

No headline names it lately.

Everyone who traded it

Alexander Y. Tokman Chief Executive Officer · last 2 Mar 20263 · 1

Richard Jacroux Chief Financial Officer · last 2 Mar 20260 · 0

Anthony Digiandomenico Director · last 21 Jan 20264 · 0

Lou Basenese Director · last 21 Jan 20265 · 2

Michael Harsh Director · last 21 Jan 20264 · 0

UBS Group AG Other · last 27 Aug 20242 · 0

Michael Milos Thornton Chief Technology Officer · last 18 May 20236 · 2

Francois Roger Michelon Chief Executive Officer · last 30 Jan 20231 · 1

Irina Pestrikova Senior Director, Finance · last 30 Jan 20230 · 0

Renaud Bertrand Maloberti Chief Commercial Officer · last 28 Mar 20220 · 7

David R. Wells Chief Financial Officer · last 5 Apr 20213 · 2

Sanjiv Sam Gambhir Director · last 9 Apr 20200 · 0

Same industry

RCEL Avita MedicalLeading+127%

HTFL HeartflowLeading+57%

ATRC AtriCureLeading+54%

PLSE Pulse BiosciencesLeading+54%

SGHT Sight SciencesLeading+50%

HAE HaemoneticsLeading+43%

INFU InfuSystems HoldingsLeading+32%

BVS BioventusLeading+31%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-186%

Share count trendFY 2025 · to 31 Mar 20265.5%

Cash and equivalentsFY 2025 · to 31 Dec 2025$762K

Free cash flowFY 2025 · to 31 Dec 2025−$5.2M

Analyst forecasts

No analyst forecasts yet.